Pleiotropic Drugs against Alzheimer’s Disease
The multifactorial nature of some diseases, and in particular neurodegenerative diseases such as Alzheimer’s disease, frequently requires the use of several drugs. These drug cocktails are not without drawbacks in terms of increased adverse effects, drug-drug interactions or adherence to treatment. The concept of pleiotropic drugs, which combine, within a single molecule, several activities directed against distinct therapeutic targets, makes it possible to overcome some of these problems. In addition, these pleiotropic drugs, generally, lead to the expression of a synergy of effects, sometimes greater than that observed with a combination of drugs. This article will review, through recent examples, the different kinds of pleiotropic drugs being studied or already present on the market of medicines..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Preprints.org - (2023) vom: 01. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thomas, Guiselin [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.20944/preprints202307.2100.v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
preprintsorg040392031 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | preprintsorg040392031 | ||
| 003 | DE-627 | ||
| 005 | 20231205144516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230802s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20944/preprints202307.2100.v1 |2 doi | |
| 024 | 7 | |a 10.20944/preprints202307.2100.v1 |2 doi | |
| 035 | |a (DE-627)preprintsorg040392031 | ||
| 035 | |a (preprintsorg)10.20944/preprints202307.2100 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thomas, Guiselin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pleiotropic Drugs against Alzheimer’s Disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The multifactorial nature of some diseases, and in particular neurodegenerative diseases such as Alzheimer’s disease, frequently requires the use of several drugs. These drug cocktails are not without drawbacks in terms of increased adverse effects, drug-drug interactions or adherence to treatment. The concept of pleiotropic drugs, which combine, within a single molecule, several activities directed against distinct therapeutic targets, makes it possible to overcome some of these problems. In addition, these pleiotropic drugs, generally, lead to the expression of a synergy of effects, sometimes greater than that observed with a combination of drugs. This article will review, through recent examples, the different kinds of pleiotropic drugs being studied or already present on the market of medicines. | ||
| 700 | 1 | |a Lecoutey, Cédric |4 aut | |
| 700 | 1 | |a Rochais, Christophe |0 (orcid)0000-0001-7996-2082 |4 aut | |
| 700 | 1 | |a Dallemagne, Patrick |0 (orcid)0000-0002-4845-615X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preprints.org |g (2023) vom: 01. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:10 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/pharmaceutics15102382 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20944/preprints202307.2100.v1 |z kostenfrei |3 Volltext |
| 912 | |a preprintsorg | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 10 | ||